Lesson’s Learned from Building out the Commercial Organization

SK Life Science breaks through Covid barriers to bring epilepsy drug to market

Lutronic’s Focus on Change during the Pandemic

From Big Pharma to Startup: What are the Challenges?

The View from Olympus: How This MedTech Leader Approached the Pandemic

DENTALEZ COO Heather Trombley on Reinvigorating the Company

Seqirus Exec on Vaccine Differentiation

Zimmer Biomet VP on Covering the Territory

How Teleflex Grew its Market Value 4x in 6 Years

Admedus COO David St. Denis on Courage, Commitment and Conversation

1 min read

AusperBio Secures $73M in Series B Funding to Advance Functional Cure for Chronic Hepatitis B

San Francisco, CA, December 26, 2024 (PRNewswire) -- AusperBio has raised $73 million in Series B funding to advance its lead therapy, AHB-137, for chronic hepatitis B. The funding will support Phase 2 clinical trials, global expansion, and scaling of manufacturing. This milestone highlights continued investor confidence and the company's potential to transform CHB treatment.

Read full article here.

Recent Posts

See All

Precigen Secures $79M in Private Placement for Series A Convertible Preferred Stock and Warrants

Germantown, MD, December 27, 2024 (PRNewswire) -- Precigen, Inc. has entered into a securities purchase agreement for the sale of its...

VectorY Therapeutics Appoints Jim Scibetta as CEO and Expands U.S. Presence

Amsterdam, Netherlands and Boston, MA, December 20, 2024 (Business Wire) -- VectorY Therapeutics has appointed Jim Scibetta as its new...

Akamis Bio Secures $60M in Series A Prime Funding to Advance Oncology Pipeline

Cambridge, MA and Oxford, England, December 17, 2024 (Business Wire) -- Akamis Bio secured $60 million in Series A Prime funding and...

Precigen Secures $79M in Private Placement for Series A Convertible Preferred Stock and Warrants

VectorY Therapeutics Appoints Jim Scibetta as CEO and Expands U.S. Presence

Akamis Bio Secures $60M in Series A Prime Funding to Advance Oncology Pipeline

Borealis Biosciences Appoints Christian Hordo as CEO and Secures $30M in Series A Extension

AusperBio Secures $73M in Series B Funding to Advance Functional Cure for Chronic Hepatitis B

Capstan Medical Secures $110M in Series C Funding to Advance Robotic Heart Valve Implants

Franklin Biolabs Appoints Dr. Vatsala Naageshwaran as CEO to Lead Genetic Medicines Innovation

SiteOne Therapeutics Secures $100M in Series C Financing to Advance Non-Opioid Pain Treatments

Pleno Appoints Dr. Vik Vaz as CEO to Lead Commercial Growth

AbbVie to Acquire Nimble Therapeutics for $200M, Expanding Autoimmune Pipeline and Peptide Innovation Platform

Insights and News Curated for Life Science Experts by Life Science Experts....

Go back to...

Executive Spotlights

AusperBio Secures $73M in Series B Funding to Advance Functional Cure for Chronic Hepatitis B

Recent Posts

Life Science Headlines